BR0212336A - Compostos bifenileno - Google Patents

Compostos bifenileno

Info

Publication number
BR0212336A
BR0212336A BR0212336-3A BR0212336A BR0212336A BR 0212336 A BR0212336 A BR 0212336A BR 0212336 A BR0212336 A BR 0212336A BR 0212336 A BR0212336 A BR 0212336A
Authority
BR
Brazil
Prior art keywords
alkyl
unsubstituted
alkoxy
mono
amino
Prior art date
Application number
BR0212336-3A
Other languages
English (en)
Inventor
Barbara Wagner
Dietmar Hueglin
Original Assignee
Ciba Sc Holding Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Sc Holding Ag filed Critical Ciba Sc Holding Ag
Publication of BR0212336A publication Critical patent/BR0212336A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C07C45/74—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/657—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
    • C07C49/683—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings having unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/794—Ketones containing a keto group bound to a six-membered aromatic ring having unsaturation outside an aromatic ring
    • C07C49/796—Ketones containing a keto group bound to a six-membered aromatic ring having unsaturation outside an aromatic ring polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C07C49/813—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C07D239/62—Barbituric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

"COMPOSTOS BIFENILENO". A presente invenção refere-se a compostos bifenileno da fórmula onde R~ 1~ é um radical C~ 1~-C~ 18~ alquila, C~ 2~-C~ 18~ alquenila, C~ 6~-C~ 10~ arila ou C~ 6~-C~ 10~ heteroarila cada um não-substituído ou mono- ou polissubstituído por hidróxi, halogênio, C~ 1~-C~ 18~ alquila, C~ 1~-C~ 18~ alcóxi, amino, C~ 1~-C~ 5~ monoalquilamino ou por di-C~ 1~-C~ 5~-alquilamino; C~ 5~-C~ 7~ cicloalquila ou C~ 5~-C~ 7~ cicloalquenila cada uma não-substituída ou substituída por C~ 1~-C~ 5~ alquila; -OR<39>; ou -NR<39>R"; R~ 2~ é um radical C~ 1~-C~ 18~ alquila, C~ 2~-C~ 18~ alquenila, C~ 6~-C~ 10~ arila ou C~ 6~-C~ 10~ heteroarila cada um não-substituído ou mono- ou polissubstituído por hidróxi, halogênio, C~ 1~-C~ 18~ alcóxi, amino, C~ 1~-C~ 5~ monoalquilamino ou por di-C~ 1~-C~ 5~-alquilamino; -OR<39>; ou NR<39>R"; ou R~ 1~ e R~ 2~ juntos formam um anel carbocílico monocíclico ou heterocíclico de 5 a 7 membros; R~ 3~ é hidrogênio; C~ 1~-C~ 6~ alquila ou C~ 1~-C~ 6~ alcóxi; R<39> e R" são, cada um independentemente do outro, hidrogênio; C~ 1~-C~ 18~ alquila C~ 5~-C~ 7~ cicloalquila ou fenila substituída com grupo mono- ou polihidróxi-, halo-, C~ 1~-C~ 18~ alquila-, C~ 1~-C~ 18~ alcóxi, amino- ou amónio quaternário-, ou não-substituída; e n é 0 ou 1; onde, quando R~ 2~ for -OR<39> ou -NR<39>R" e n=1, R~ 1~ não seja simultaneamente -OR' ou -NR<39>R". Os compostos de acordo com a invenção são adequados especialmente como agentes de proteção solar em preparações cosméticas, farmacêuticas e de medicina veterinária.
BR0212336-3A 2001-09-07 2002-08-29 Compostos bifenileno BR0212336A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01810861 2001-09-07
CH10592002 2002-06-20
PCT/EP2002/009627 WO2003022790A2 (en) 2001-09-07 2002-08-29 Biphenylene compounds

Publications (1)

Publication Number Publication Date
BR0212336A true BR0212336A (pt) 2004-09-21

Family

ID=25738884

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0212336-3A BR0212336A (pt) 2001-09-07 2002-08-29 Compostos bifenileno

Country Status (6)

Country Link
US (1) US7432400B2 (pt)
EP (1) EP1423351A2 (pt)
JP (1) JP4230353B2 (pt)
CN (1) CN1553888A (pt)
BR (1) BR0212336A (pt)
WO (1) WO2003022790A2 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2018006918A (es) * 2015-12-08 2018-11-09 Kemira Oyj Composiciones polimericas liquidas.
CN114933520B (zh) * 2022-06-01 2023-09-22 山西大学 一种光催化聚合用有机小分子材料及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2540380B1 (fr) * 1983-02-03 1986-02-07 Oreal Composition cosmetique pour la protection contre le rayonnement ultraviolet et son utilisation a cet effet
EP1117638B1 (en) * 1998-10-02 2004-03-17 Ciba SC Holding AG Biphenyl compounds substituted by camphor or hydantoin derivatives as sunscreen compositions

Also Published As

Publication number Publication date
WO2003022790A3 (en) 2003-09-04
JP4230353B2 (ja) 2009-02-25
CN1553888A (zh) 2004-12-08
WO2003022790A2 (en) 2003-03-20
US20040265248A1 (en) 2004-12-30
EP1423351A2 (en) 2004-06-02
US7432400B2 (en) 2008-10-07
JP2005502693A (ja) 2005-01-27

Similar Documents

Publication Publication Date Title
ES2672203T3 (es) Aminas heterocíclicas y usos de las mismas
BR112022009514A2 (pt) Compostos úteis como inibidores de proteína helios
CN113717156A (zh) Egfr抑制剂、其制备方法及用途
BR9809697A (pt) Composto, uso, e processo para a preparação do mesmo, composição farmacêutica, e, processo para tratar uma doença de um corpo de animal vivo, incluindo um humano
AR072906A1 (es) Nucleosidos modificados utiles como antivirales
HUP0202703A2 (hu) Poli(ADP-ribóz) polimerázok triciklusos inhibítorai és ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
WO2023030685A1 (en) Novel ras inhibitors
AR064608A1 (es) Derivados de pirazolo-quinazolina sustituidos, composiciones farmaceuticas que los contienen. proceso para su preparacion y uso de los mismos como agentes anticancer.
DE60238066D1 (de) Triazinderivate und deren verwendung als sonnenschutzmittel
BRPI0413616A (pt) 2,4-pirimidinadiaminas úteis no tratamento de doenças neoplásicas, distúrbios inflamatórios e distúrbios do sistema imunológico
BR0014137A (pt) Composto, método para inibir a aurora 2 quinase em um animal de sangue quente, uso de um composto, e, composição farmacêutica
BRPI0517343A (pt) derivados de betulina, preparação destes e uso dos mesmos
AR035885A1 (es) Derivados de 4-amino-5-fenil-7-ciclobutilpirrolo (2,3-d)pirimidina, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la preparacion de una composicion farmaceutica
BR112013007696A2 (pt) composto, composição farmacêutica, usos do referido composto e da referida composição
AR066659A1 (es) Derivados de espiroindolinona
BR9812048A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos de tratar uma doença mediada por uma cinase, de tratar a rejeição no transplante de órgão, e de tratar a alopecia induzida pela quimioterapia
CY1107108T1 (el) Παραγωγα αρυλομεθυλο-καρβονυλαμινο-θειαζολης και χρησις των ως αντινεοπλασματικοι παραγοντες
BR112012010085A2 (pt) inibidores de quinases
AR017852A1 (es) COMPUESTOS DE PIRAZOLO (3,4-b)PIRIDINA Y SUS SALES, UTILES COMO INHIBIDORES DE LAS PROTEINA-QUINASAS DEPENDIENTES DE CICLINA, Y LAS COMPOSICIONESFARMACEUTICAS QUE LOS CONTIENEN, EVENTUALMENTE ASOCIADOS CON UN AGENTE ANTICANCER.
PE20220567A1 (es) Nuevos derivados piperidinilo, un proceso para su preparacion y composiciones farmaceuticas que los contienen
CY1113323T1 (el) Ενωσεις τετραϋδροφουρο[3,4-d]διοξολανιου για χρηση στη θεραπεια ιικων μολυνσεων και καρκινου
AR072622A1 (es) Derivados de imidazo[2,1-b][1,3,4]tiadiazol, composiciones farmaceuticas que los comprenden, metodo para prepararlos, y uso de los mismos para el tratamiento de tumores y otras enfermedades inducidas por quinasas
Gawali et al. Design, synthesis, docking studies and biological screening of 2-thiazolyl substituted-2, 3-dihydro-1H-naphtho [1, 2-e][1, 3] oxazines as potent HIV-1 reverse transcriptase inhibitors
MXPA05007494A (es) Nuevos compuestos.
EA201000101A1 (ru) Производные пиримидина 934

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A,7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2060 DE 29/06/2010.

B15K Others concerning applications: alteration of classification

Ipc: C07D 453/02 (2006.01), A61K 8/35 (2006.01), A61Q 1